Company: BKYI
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001437749-25-016136
Chunk: 5

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-05-12
Form: 424B3
Chunk 5
---
 program which we have grown to more than eighty-five participants and continues to generate incremental revenues.

A second component of our growth strategy is to pursue strategic acquisitions of select businesses and assets in the IAM space. In furtherance of this strategy, we are active in the industry and regularly evaluate businesses that we believe will either provide an entry into new market verticals or be synergistic with our existing operations and in either case, be accretive to earnings. We cannot provide any assurance as to whether we will be able to complete any acquisition and if completed, successfully integrate any business we acquire into our operations.

General

Our principal executive office is located at 101 Crawfords Corner Road, Suite 4116, Holmdel, New Jersey 07733 and our telephone number is (732) 359-1100. Our website is located at www.bio-key.com. The information on our website or any other website is not incorporated by reference into this prospectus. Our website address is included as an inactive textual reference only.

The BIO-key logo is our trademark. This prospectus and the documents we incorporate by reference into this prospectus may also contain trademarks and trade names of others.

<div align='center'>3</div>

The Offering

| Issuer:                                                                                                                                                             | BIO-key International, Inc.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Common stock offered by selling stockholder:                                                                                                                        | 3,091,668 shares of common stock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Common stock outstanding before this offering:                                                                                                                      | 5,814,041 shares of common stock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Common stock outstanding after completion of this offering (assuming full exercise of the warrants that are exercisable for shares of common stock offered hereby): | 8,905,709 shares of common stock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Terms of this offering:                                                                                                                                             | The selling stockholder, including its transferees, donees, pledgees, assignees and successors-in-interest, may sell, transfer or otherwise dispose of any or all of the shares of common stock offered by this prospectus from time to time on the Nasdaq Capital Market or any other stock exchange, market or trading facility on which the shares are traded or in private transactions. The shares of common stock may be sold at fixed prices, at market prices prevailing at the time of sale, at prices related to prevailing market price, or at negotiated prices.                                     |
| Use of proceeds:                                                                                                                                                    | The proceeds from the sale of the securities covered by this prospect